Asset view · 8 November 2026

European equities: what research is saying

From 183 research houses — 66 asset managers, 53 banks, 38 independent research firms and 26 podcasts. Names are shown to members. See who said what, free →

AI summary of published research · 8 November 2026

European equities caught a tailwind this week as published research leaned into the "rotate out of US tech, into everything else" trade.

The dominant thread across analysts: a weaker dollar, narrowing US policy premium and crowded positioning in US technology make Europe a natural beneficiary of diversification flows. Several notes singled out the Eurozone as a preferred region, with Poland, Spain and Italy flagged as value pockets. Energy was another throughline — researchers argued that any de-escalation in the Middle East, and lower oil prices, disproportionately help energy-importing Europe.

Sector views were busier than usual. One strand sees European banks and consumer staples as hiding places if the AI sell-off broadens, noting Europe is a consensus underweight. Clean energy names rallied on US midterm readings seen as friendlier to the transition. On single stocks, constructive technical setups were flagged on AstraZeneca, Bayer and Ferrari, while Rheinmetall drew a bearish read after results.

The caveats: slowing earnings momentum, sticky energy costs, and a warning that higher real yields are squeezing non-AI equal-weight indices on both sides of the Atlantic.

Investment themes on European equities now

Free · by email · no account

The Daily Digest in your inbox

Every morning, what published research argued the day before: the cross-asset and macro read in full, then every market in a line.

One-click unsubscribe in every email.